| Period | Weighting | Quarter | ||||||
|---|---|---|---|---|---|---|---|---|
| Company | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| NORDEA INVESTMENT MANAGEMENT AB | 6 | 1 | 0.00% | 0.00% | 0.01% | Q4 2015 | Q3 2017 | 7 |
| Airain ltd | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2016 | Q1 2016 | 1 |
| REILLY FINANCIAL ADVISORS, LLC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2015 | Q2 2015 | 1 |
| Analyst IMS Investment Management Services Ltd. | 1 | 1 | 0.42% | 0.42% | 0.42% | Q1 2015 | Q1 2015 | 1 |
| Plaisance Capital LLC | 1 | 1 | 0.45% | 0.45% | 0.45% | Q3 2020 | Q3 2020 | 1 |
| NN Investment Partners Holdings N.V. | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2017 | Q3 2017 | 1 |
This page lists all the filers that currently own Taro Pharmaceutical Industries or have owned Taro Pharmaceutical Industries in the past.